Global Oxycodone Market Key Facts, Dynamics, Segments, And Forecast Predictions By 2030

Global Oxycodone Market Size, Growth, Trends, And Global Segments Analysis Report to 2030
The global oxycodone market is anticipated to attain a notable CAGR over the forecast
period, i.e., 2022 – 2030. The market is segmented by route of administration into oral,
intravenous, and others. Among these segments, the oral segment is anticipated to gain
the largest market share over the forecast period owing to the safer action of oxycodone
when administered orally. Moreover, the oxycodone tablets contain other drugs, which
reduces the abuse potential of the drug, which is estimated to boost the segment
growth.
The global oxycodone market is estimated to grow on the back of growing cases of
cancer globally. As per the data by the National Cancer Institute, over 18.1 million new
cases of cancer were reported globally in 2018. Moreover, the growing medical
research activities, along with rising investment in the R&D activities in healthcare
sector, are estimated to boost the market growth. Furthermore, oxycodone has lower
growth.
Research Nester published a report titled “Oxycodone Market: Global Demand
Analysis & Opportunity Outlook 2030” which delivers a detailed overview of the
global oxycodone market in terms of market segmentation by route of administration,
application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion on current
and future market trends that are associated with the growth of the market.
On the basis of geographical analysis, the global oxycodone market is segmented into
five major regions including North America, Europe, Asia Pacific, Latin America and
Middle East & Africa region. The market in the North America region is anticipated to
gain the largest market share throughout the forecast period owing to the rising cases of
cancer in developed nations, along with the presence of major research institutes in the
region,. According to the US National Cancer Institute, an estimated of 1,806,590 new
cases of cancer were diagnosed in the United States in 2020. Moreover, high
healthcare expenditure, and increasing R&D activities, are estimated to boost the
market growth.
The research is global in nature and covers detailed analysis on the market in North
America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary,
Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark],
Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest
of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore,
Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel,
GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa,
Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y
growth & opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and displayed in
the research report.
Get a Sample Copy Of This Report With Graphs and
Charts: https://www.researchnester.com/sample-request-3794
Rising Prevalence of Cancer Globally to Boost the Market Growth
According to the data by the World Health Organization (WHO), the cancer mortality
rate grew from 9.6 million in 2018 to over 10 million in 2020.
Oxycodone is prescribed to cancer patients who experience extreme pain. It is generally
given on a regular basis, as it is less addictive, when taken orally. Moreover, the
growing demand for opium-based analgesics to relieve the pain for cancer patients is
anticipated to boost the market growth.
However, the side effects and addictive nature of opioids are expected to operate as
key restraint to the growth of global oxycodone marketover the forecast period.
This report also provides the existing competitive scenario of some of the key players of
the global oxycodone marketwhich includes company profiling of Thermo Fisher
Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck &
Co., Inc., Esteve Pharmaceuticals, S.A., Validus Pharmaceuticals LLC, Teva
key information of the companies which encompasses business overview, products and
services, key financials and recent news and developments. On the whole, the report
depicts detailed overview of the global oxycodone marketthat will help industry
consultants, equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to align their
market centric strategies according to the ongoing and expected trends in the future.
Get a PDF Sample For More Detailed Market
Insights: https://www.researchnester.com/sample-request-3794
About Us
Research Nester is a leading service provider for strategic market research and
consulting. We aim to provide unbiased, unparalleled market insights and industry
analysis to help industries, conglomerates and executives to take wise decisions for
their future marketing strategy, expansion and investment etc. We believe every
business can expand to its new horizon, provided a right guidance at a right time is
available through strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more Info: